Workflow
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
10x Genomics10x Genomics(US:TXG) Zacks Investment Research·2024-04-23 01:01

10x Genomics盈利情况 - 10x Genomics最近被升级为Zacks Rank 2 (Buy),这是因为其盈利预期呈上升趋势[1] - 10x Genomics的Zacks评级升级实际上是对其盈利前景的积极评价,可能对其股价产生有利影响[4] - 10x Genomics的盈利预期逐渐上升,过去三个月,公司的Zacks共识估计增长了5%[10] - 10x Genomics被升级为Zacks Rank 2,使其在Zacks覆盖的股票中处于前20%,暗示股价可能在短期内上涨[13]